0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global IV Infusion Set Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-18Z17385
Home | Market Reports | Health| Medical Devices & Equipment
Global IV Infusion Set Market Research Report 2024
BUY CHAPTERS

Global IV Infusion Set Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-18Z17385
Report
October 2025
Pages:172
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

IV Infusion Set Market

The global IV Infusion Set market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
From a downstream perspective, Hospitals accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
IV Infusion Set leading manufacturers including Vitrex Medical, Micrel Medical Devices, Tecnoline, Sunrise Medical, INT Medical, Kapsam, Shuangwei, GenSci Group, Baihe Medical, Runqiang Medical, etc., dominate supply; the top five capture approximately % of global revenue, with Vitrex Medical leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global IV Infusion Set market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of IV Infusion Set Market Report

Report Metric Details
Report Name IV Infusion Set Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Vitrex Medical, Micrel Medical Devices, Tecnoline, Sunrise Medical, INT Medical, Kapsam, Shuangwei, GenSci Group, Baihe Medical, Runqiang Medical, Baxter, Nipro, Braun Medical, Lily Medical, Angiplast, Nishi Medcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the IV Infusion Set study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the IV Infusion Set Market report?

Ans: The main players in the IV Infusion Set Market are Vitrex Medical, Micrel Medical Devices, Tecnoline, Sunrise Medical, INT Medical, Kapsam, Shuangwei, GenSci Group, Baihe Medical, Runqiang Medical, Baxter, Nipro, Braun Medical, Lily Medical, Angiplast, Nishi Medcare

What are the Application segmentation covered in the IV Infusion Set Market report?

Ans: The Applications covered in the IV Infusion Set Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the IV Infusion Set Market report?

Ans: The Types covered in the IV Infusion Set Market report are Filtered IV Sets, Vented IV Sets, Non-Vented IV Sets, Gravity Tubing

Recommended Reports

IV Infusion Devices

Infusion Set Products

IV Administration & Accessories

1 Study Coverage
1.1 Introduction to IV Infusion Set: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global IV Infusion Set Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Filtered IV Sets
1.2.3 Vented IV Sets
1.2.4 Non-Vented IV Sets
1.2.5 Gravity Tubing
1.3 Market Segmentation by Application
1.3.1 Global IV Infusion Set Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global IV Infusion Set Revenue Estimates and Forecasts 2020-2031
2.2 Global IV Infusion Set Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global IV Infusion Set Sales Estimates and Forecasts 2020-2031
2.4 Global IV Infusion Set Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global IV Infusion Set Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global IV Infusion Set Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Filtered IV Sets Market Size by Manufacturers
3.5.2 Vented IV Sets Market Size by Manufacturers
3.5.3 Non-Vented IV Sets Market Size by Manufacturers
3.5.4 Gravity Tubing Market Size by Manufacturers
3.6 Global IV Infusion Set Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global IV Infusion Set Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global IV Infusion Set Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global IV Infusion Set Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global IV Infusion Set Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America IV Infusion Set Sales and Revenue by Type (2020-2031)
6.4 North America IV Infusion Set Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America IV Infusion Set Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe IV Infusion Set Sales and Revenue by Type (2020-2031)
7.4 Europe IV Infusion Set Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe IV Infusion Set Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific IV Infusion Set Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific IV Infusion Set Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific IV Infusion Set Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America IV Infusion Set Sales and Revenue by Type (2020-2031)
9.4 Central and South America IV Infusion Set Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America IV Infusion Set Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa IV Infusion Set Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa IV Infusion Set Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa IV Infusion Set Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Vitrex Medical
11.1.1 Vitrex Medical Corporation Information
11.1.2 Vitrex Medical Business Overview
11.1.3 Vitrex Medical IV Infusion Set Product Models, Descriptions and Specifications
11.1.4 Vitrex Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Vitrex Medical IV Infusion Set Sales by Product in 2024
11.1.6 Vitrex Medical IV Infusion Set Sales by Application in 2024
11.1.7 Vitrex Medical IV Infusion Set Sales by Geographic Area in 2024
11.1.8 Vitrex Medical IV Infusion Set SWOT Analysis
11.1.9 Vitrex Medical Recent Developments
11.2 Micrel Medical Devices
11.2.1 Micrel Medical Devices Corporation Information
11.2.2 Micrel Medical Devices Business Overview
11.2.3 Micrel Medical Devices IV Infusion Set Product Models, Descriptions and Specifications
11.2.4 Micrel Medical Devices IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Micrel Medical Devices IV Infusion Set Sales by Product in 2024
11.2.6 Micrel Medical Devices IV Infusion Set Sales by Application in 2024
11.2.7 Micrel Medical Devices IV Infusion Set Sales by Geographic Area in 2024
11.2.8 Micrel Medical Devices IV Infusion Set SWOT Analysis
11.2.9 Micrel Medical Devices Recent Developments
11.3 Tecnoline
11.3.1 Tecnoline Corporation Information
11.3.2 Tecnoline Business Overview
11.3.3 Tecnoline IV Infusion Set Product Models, Descriptions and Specifications
11.3.4 Tecnoline IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Tecnoline IV Infusion Set Sales by Product in 2024
11.3.6 Tecnoline IV Infusion Set Sales by Application in 2024
11.3.7 Tecnoline IV Infusion Set Sales by Geographic Area in 2024
11.3.8 Tecnoline IV Infusion Set SWOT Analysis
11.3.9 Tecnoline Recent Developments
11.4 Sunrise Medical
11.4.1 Sunrise Medical Corporation Information
11.4.2 Sunrise Medical Business Overview
11.4.3 Sunrise Medical IV Infusion Set Product Models, Descriptions and Specifications
11.4.4 Sunrise Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sunrise Medical IV Infusion Set Sales by Product in 2024
11.4.6 Sunrise Medical IV Infusion Set Sales by Application in 2024
11.4.7 Sunrise Medical IV Infusion Set Sales by Geographic Area in 2024
11.4.8 Sunrise Medical IV Infusion Set SWOT Analysis
11.4.9 Sunrise Medical Recent Developments
11.5 INT Medical
11.5.1 INT Medical Corporation Information
11.5.2 INT Medical Business Overview
11.5.3 INT Medical IV Infusion Set Product Models, Descriptions and Specifications
11.5.4 INT Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 INT Medical IV Infusion Set Sales by Product in 2024
11.5.6 INT Medical IV Infusion Set Sales by Application in 2024
11.5.7 INT Medical IV Infusion Set Sales by Geographic Area in 2024
11.5.8 INT Medical IV Infusion Set SWOT Analysis
11.5.9 INT Medical Recent Developments
11.6 Kapsam
11.6.1 Kapsam Corporation Information
11.6.2 Kapsam Business Overview
11.6.3 Kapsam IV Infusion Set Product Models, Descriptions and Specifications
11.6.4 Kapsam IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Kapsam Recent Developments
11.7 Shuangwei
11.7.1 Shuangwei Corporation Information
11.7.2 Shuangwei Business Overview
11.7.3 Shuangwei IV Infusion Set Product Models, Descriptions and Specifications
11.7.4 Shuangwei IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Shuangwei Recent Developments
11.8 GenSci Group
11.8.1 GenSci Group Corporation Information
11.8.2 GenSci Group Business Overview
11.8.3 GenSci Group IV Infusion Set Product Models, Descriptions and Specifications
11.8.4 GenSci Group IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 GenSci Group Recent Developments
11.9 Baihe Medical
11.9.1 Baihe Medical Corporation Information
11.9.2 Baihe Medical Business Overview
11.9.3 Baihe Medical IV Infusion Set Product Models, Descriptions and Specifications
11.9.4 Baihe Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Baihe Medical Recent Developments
11.10 Runqiang Medical
11.10.1 Runqiang Medical Corporation Information
11.10.2 Runqiang Medical Business Overview
11.10.3 Runqiang Medical IV Infusion Set Product Models, Descriptions and Specifications
11.10.4 Runqiang Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Runqiang Medical Recent Developments
11.11 Baxter
11.11.1 Baxter Corporation Information
11.11.2 Baxter Business Overview
11.11.3 Baxter IV Infusion Set Product Models, Descriptions and Specifications
11.11.4 Baxter IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Baxter Recent Developments
11.12 Nipro
11.12.1 Nipro Corporation Information
11.12.2 Nipro Business Overview
11.12.3 Nipro IV Infusion Set Product Models, Descriptions and Specifications
11.12.4 Nipro IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Nipro Recent Developments
11.13 Braun Medical
11.13.1 Braun Medical Corporation Information
11.13.2 Braun Medical Business Overview
11.13.3 Braun Medical IV Infusion Set Product Models, Descriptions and Specifications
11.13.4 Braun Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Braun Medical Recent Developments
11.14 Lily Medical
11.14.1 Lily Medical Corporation Information
11.14.2 Lily Medical Business Overview
11.14.3 Lily Medical IV Infusion Set Product Models, Descriptions and Specifications
11.14.4 Lily Medical IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Lily Medical Recent Developments
11.15 Angiplast
11.15.1 Angiplast Corporation Information
11.15.2 Angiplast Business Overview
11.15.3 Angiplast IV Infusion Set Product Models, Descriptions and Specifications
11.15.4 Angiplast IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Angiplast Recent Developments
11.16 Nishi Medcare
11.16.1 Nishi Medcare Corporation Information
11.16.2 Nishi Medcare Business Overview
11.16.3 Nishi Medcare IV Infusion Set Product Models, Descriptions and Specifications
11.16.4 Nishi Medcare IV Infusion Set Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 Nishi Medcare Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 IV Infusion Set Industry Chain
12.2 IV Infusion Set Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 IV Infusion Set Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 IV Infusion Set Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 IV Infusion Set Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global IV Infusion Set Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global IV Infusion Set Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global IV Infusion Set Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global IV Infusion Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global IV Infusion Set Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global IV Infusion Set Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global IV Infusion Set Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global IV Infusion Set Sales by Region (2020-2025) & (Units)
 Table 8. Global IV Infusion Set Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global IV Infusion Set Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global IV Infusion Set Sales Share by Manufacturers (2020-2025)
 Table 12. Global IV Infusion Set Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global IV Infusion Set Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global IV Infusion Set by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IV Infusion Set as of 2024)
 Table 16. Global IV Infusion Set Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global IV Infusion Set Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers IV Infusion Set Manufacturing Base and Headquarters
 Table 19. Global IV Infusion Set Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global IV Infusion Set Sales by Type (2020-2025) & (Units)
 Table 23. Global IV Infusion Set Sales by Type (2026-2031) & (Units)
 Table 24. Global IV Infusion Set Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global IV Infusion Set Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global IV Infusion Set ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global IV Infusion Set Sales by Application (2020-2025) & (Units)
 Table 29. Global IV Infusion Set Sales by Application (2026-2031) & (Units)
 Table 30. IV Infusion Set High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global IV Infusion Set Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global IV Infusion Set Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global IV Infusion Set ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America IV Infusion Set Growth Accelerators and Market Barriers
 Table 37. North America IV Infusion Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America IV Infusion Set Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe IV Infusion Set Growth Accelerators and Market Barriers
 Table 40. Europe IV Infusion Set Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe IV Infusion Set Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific IV Infusion Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific IV Infusion Set Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific IV Infusion Set Growth Accelerators and Market Barriers
 Table 45. Southeast Asia IV Infusion Set Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America IV Infusion Set Investment Opportunities and Key Challenges
 Table 47. Central and South America IV Infusion Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa IV Infusion Set Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa IV Infusion Set Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Vitrex Medical Corporation Information
 Table 51. Vitrex Medical Description and Major Businesses
 Table 52. Vitrex Medical Product Models, Descriptions and Specifications
 Table 53. Vitrex Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Vitrex Medical Sales Value Proportion by Product in 2024
 Table 55. Vitrex Medical Sales Value Proportion by Application in 2024
 Table 56. Vitrex Medical Sales Value Proportion by Geographic Area in 2024
 Table 57. Vitrex Medical IV Infusion Set SWOT Analysis
 Table 58. Vitrex Medical Recent Developments
 Table 59. Micrel Medical Devices Corporation Information
 Table 60. Micrel Medical Devices Description and Major Businesses
 Table 61. Micrel Medical Devices Product Models, Descriptions and Specifications
 Table 62. Micrel Medical Devices Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Micrel Medical Devices Sales Value Proportion by Product in 2024
 Table 64. Micrel Medical Devices Sales Value Proportion by Application in 2024
 Table 65. Micrel Medical Devices Sales Value Proportion by Geographic Area in 2024
 Table 66. Micrel Medical Devices IV Infusion Set SWOT Analysis
 Table 67. Micrel Medical Devices Recent Developments
 Table 68. Tecnoline Corporation Information
 Table 69. Tecnoline Description and Major Businesses
 Table 70. Tecnoline Product Models, Descriptions and Specifications
 Table 71. Tecnoline Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Tecnoline Sales Value Proportion by Product in 2024
 Table 73. Tecnoline Sales Value Proportion by Application in 2024
 Table 74. Tecnoline Sales Value Proportion by Geographic Area in 2024
 Table 75. Tecnoline IV Infusion Set SWOT Analysis
 Table 76. Tecnoline Recent Developments
 Table 77. Sunrise Medical Corporation Information
 Table 78. Sunrise Medical Description and Major Businesses
 Table 79. Sunrise Medical Product Models, Descriptions and Specifications
 Table 80. Sunrise Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Sunrise Medical Sales Value Proportion by Product in 2024
 Table 82. Sunrise Medical Sales Value Proportion by Application in 2024
 Table 83. Sunrise Medical Sales Value Proportion by Geographic Area in 2024
 Table 84. Sunrise Medical IV Infusion Set SWOT Analysis
 Table 85. Sunrise Medical Recent Developments
 Table 86. INT Medical Corporation Information
 Table 87. INT Medical Description and Major Businesses
 Table 88. INT Medical Product Models, Descriptions and Specifications
 Table 89. INT Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. INT Medical Sales Value Proportion by Product in 2024
 Table 91. INT Medical Sales Value Proportion by Application in 2024
 Table 92. INT Medical Sales Value Proportion by Geographic Area in 2024
 Table 93. INT Medical IV Infusion Set SWOT Analysis
 Table 94. INT Medical Recent Developments
 Table 95. Kapsam Corporation Information
 Table 96. Kapsam Description and Major Businesses
 Table 97. Kapsam Product Models, Descriptions and Specifications
 Table 98. Kapsam Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Kapsam Recent Developments
 Table 100. Shuangwei Corporation Information
 Table 101. Shuangwei Description and Major Businesses
 Table 102. Shuangwei Product Models, Descriptions and Specifications
 Table 103. Shuangwei Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 104. Shuangwei Recent Developments
 Table 105. GenSci Group Corporation Information
 Table 106. GenSci Group Description and Major Businesses
 Table 107. GenSci Group Product Models, Descriptions and Specifications
 Table 108. GenSci Group Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 109. GenSci Group Recent Developments
 Table 110. Baihe Medical Corporation Information
 Table 111. Baihe Medical Description and Major Businesses
 Table 112. Baihe Medical Product Models, Descriptions and Specifications
 Table 113. Baihe Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 114. Baihe Medical Recent Developments
 Table 115. Runqiang Medical Corporation Information
 Table 116. Runqiang Medical Description and Major Businesses
 Table 117. Runqiang Medical Product Models, Descriptions and Specifications
 Table 118. Runqiang Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 119. Runqiang Medical Recent Developments
 Table 120. Baxter Corporation Information
 Table 121. Baxter Description and Major Businesses
 Table 122. Baxter Product Models, Descriptions and Specifications
 Table 123. Baxter Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 124. Baxter Recent Developments
 Table 125. Nipro Corporation Information
 Table 126. Nipro Description and Major Businesses
 Table 127. Nipro Product Models, Descriptions and Specifications
 Table 128. Nipro Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 129. Nipro Recent Developments
 Table 130. Braun Medical Corporation Information
 Table 131. Braun Medical Description and Major Businesses
 Table 132. Braun Medical Product Models, Descriptions and Specifications
 Table 133. Braun Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 134. Braun Medical Recent Developments
 Table 135. Lily Medical Corporation Information
 Table 136. Lily Medical Description and Major Businesses
 Table 137. Lily Medical Product Models, Descriptions and Specifications
 Table 138. Lily Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 139. Lily Medical Recent Developments
 Table 140. Angiplast Corporation Information
 Table 141. Angiplast Description and Major Businesses
 Table 142. Angiplast Product Models, Descriptions and Specifications
 Table 143. Angiplast Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 144. Angiplast Recent Developments
 Table 145. Nishi Medcare Corporation Information
 Table 146. Nishi Medcare Description and Major Businesses
 Table 147. Nishi Medcare Product Models, Descriptions and Specifications
 Table 148. Nishi Medcare Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 149. Nishi Medcare Recent Developments
 Table 150. Key Raw Materials Distribution
 Table 151. Raw Materials Key Suppliers
 Table 152. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 153. Milestones in Production Technology Evolution
 Table 154. Distributors List
 Table 155. Market Trends and Market Evolution
 Table 156. Market Drivers and Opportunities
 Table 157. Market Challenges, Risks, and Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources


List of Figures
 Figure 1. IV Infusion Set Product Picture
 Figure 2. Global IV Infusion Set Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Filtered IV Sets Product Picture
 Figure 4. Vented IV Sets Product Picture
 Figure 5. Non-Vented IV Sets Product Picture
 Figure 6. Gravity Tubing Product Picture
 Figure 7. Global IV Infusion Set Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. IV Infusion Set Report Years Considered
 Figure 12. Global IV Infusion Set Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 14. Global IV Infusion Set Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 15. Global IV Infusion Set Revenue Market Share by Region (2020-2031)
 Figure 16. Global IV Infusion Set Sales (2020-2031) & (Units)
 Figure 17. Global IV Infusion Set Sales (CAGR) by Region (2020-2031) (Units)
 Figure 18. Global IV Infusion Set Sales Market Share by Region (2020-2031)
 Figure 19. Top 5 and Top 10 Manufacturers IV Infusion Set Sales Volume Market Share in 2024
 Figure 20. Global IV Infusion Set Revenue Market Share Ranking (2024)
 Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 22. Filtered IV Sets Revenue Market Share by Manufacturer in 2024
 Figure 23. Vented IV Sets Revenue Market Share by Manufacturer in 2024
 Figure 24. Non-Vented IV Sets Revenue Market Share by Manufacturer in 2024
 Figure 25. Gravity Tubing Revenue Market Share by Manufacturer in 2024
 Figure 26. Global IV Infusion Set Sales Market Share by Type (2020-2031)
 Figure 27. Global IV Infusion Set Revenue Market Share by Type (2020-2031)
 Figure 28. Global IV Infusion Set Sales Market Share by Application (2020-2031)
 Figure 29. Global IV Infusion Set Revenue Market Share by Application (2020-2031)
 Figure 30. North America IV Infusion Set Sales YoY (2020-2031) & (Units)
 Figure 31. North America IV Infusion Set Revenue YoY (2020-2031) & (US$ Million)
 Figure 32. North America Top 5 Manufacturers IV Infusion Set Sales Revenue (US$ Million) in 2024
 Figure 33. North America IV Infusion Set Sales Volume (Units) by Type (2020- 2031)
 Figure 34. North America IV Infusion Set Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 35. North America IV Infusion Set Sales Volume (Units) by Application (2020-2031)
 Figure 36. North America IV Infusion Set Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 37. US IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 38. Canada IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 39. Mexico IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 40. Europe IV Infusion Set Sales YoY (2020-2031) & (Units)
 Figure 41. Europe IV Infusion Set Revenue YoY (2020-2031) & (US$ Million)
 Figure 42. Europe Top 5 Manufacturers IV Infusion Set Sales Revenue (US$ Million) in 2024
 Figure 43. Europe IV Infusion Set Sales Volume (Units) by Type (2020-2031)
 Figure 44. Europe IV Infusion Set Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 45. Europe IV Infusion Set Sales Volume (Units) by Application (2020-2031)
 Figure 46. Europe IV Infusion Set Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 47. Germany IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 48. France IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 49. U.K. IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 50. Italy IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 51. Russia IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific IV Infusion Set Sales YoY (2020-2031) & (Units)
 Figure 53. Asia-Pacific IV Infusion Set Revenue YoY (2020-2031) & (US$ Million)
 Figure 54. Asia-Pacific Top 8 Manufacturers IV Infusion Set Sales Revenue (US$ Million) in 2024
 Figure 55. Asia-Pacific IV Infusion Set Sales Volume (Units) by Type (2020- 2031)
 Figure 56. Asia-Pacific IV Infusion Set Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 57. Asia-Pacific IV Infusion Set Sales Volume (Units) by Application (2020-2031)
 Figure 58. Asia-Pacific IV Infusion Set Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 59. Indonesia IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 60. Japan IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 61. South Korea IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 62. China Taiwan IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 63. India IV Infusion Set Revenue (2020-2031) & (US$ Million)
 Figure 64. Central and South America IV Infusion Set Sales YoY (2020-2031) & (Units)
 Figure 65. Central and South America IV Infusion Set Revenue YoY (2020-2031) & (US$ Million)
 Figure 66. Central and South America Top 5 Manufacturers IV Infusion Set Sales Revenue (US$ Million) in 2024
 Figure 67. Central and South America IV Infusion Set Sales Volume (Units) by Type (2021-2031)
 Figure 68. Central and South America IV Infusion Set Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 69. Central and South America IV Infusion Set Sales Volume (Units) by Application (2020-2031)
 Figure 70. Central and South America IV Infusion Set Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 71. Brazil IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 72. Argentina IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 73. Middle East, and Africa IV Infusion Set Sales YoY (2020-2031) & (Units)
 Figure 74. Middle East and Africa IV Infusion Set Revenue YoY (2020-2031) & (US$ Million)
 Figure 75. Middle East and Africa Top 5 Manufacturers IV Infusion Set Sales Revenue (US$ Million) in 2024
 Figure 76. Middle East and Africa IV Infusion Set Sales Volume (Units) by Type (2021-2031)
 Figure 77. South America IV Infusion Set Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 78. Middle East and Africa IV Infusion Set Sales Volume (Units) by Application (2020-2031)
 Figure 79. Middle East and Africa IV Infusion Set Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 80. GCC Countries IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 81. Turkey IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 82. Egypt IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 83. South Africa IV Infusion Set Revenue (2020-2025) & (US$ Million)
 Figure 84. IV Infusion Set Industry Chain Mapping
 Figure 85. Regional IV Infusion Set Manufacturing Base Distribution (%)
 Figure 86. Global IV Infusion Set Production Market Share by Region (2020-2031)
 Figure 87. IV Infusion Set Production Process
 Figure 88. Regional IV Infusion Set Production Cost Structure
 Figure 89. Channels of Distribution (Direct Vs Distribution)
 Figure 90. Bottom-up and Top-down Approaches for This Report
 Figure 91. Data Triangulation
 Figure 92. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart